Wednesday, August 5, 2026

HomeBusiness NewsFresh data backs Amplia push against pancreatic, ovarian cancer

Fresh data backs Amplia push against pancreatic, ovarian cancer

- Advertisement -

Brought to you by BULLS N’ BEARSDoug BrightJuly 31, 2026 — 1:15pmSaveYou have reached your maximum number of saved items.Remove items from your saved list to add more.AAAAmplia Therapeutics has received encouraging lab results which highlighted the use of its lead drug narmafotinib, saying…


Click here to view the original article.

- Advertisment -
- Advertisement -

Recently Viewed